ArticleHarm reduction journal2026
Lessons from COVID-19 for improving delivery of medications for opioid use disorder in future pandemic events: results from a Puerto Rico Delphi consensus panel.
Article in Harm reduction journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundCOVID-19 severely disrupted the provision of medications for opioid use disorder (MOUD) everywhere. Yet, while MOUD has proven to reduce mortality and other drug-related harms, no comprehensive guidelines exist to deliver treatment during a future pandemic.
methodsFrom June to November 2023, (N = 12) stakeholders with professional backgrounds in MOUD delivery and policy, including one patient located in San Juan, Puerto Rico, were recruited to deliver policy recommendations on pandemic preparedness. A Delphi consensus approach was employed in three rounds of consultations utilizing an anonymous Qualtrics survey format that included informed consent information. Panelists responded to an initial set of 26 statements across four domains: providing treatment, testing and vaccination, overdose prevention, and emergency preparedness which were revised based on ratings and narrative responses from each round.
resultsConsensus was reached on 22 statements, and panelists produced five majority recommendations. Panelists produced comprehensive guidance on policies to provide MOUD in a future pandemic, including recommendations that clinics provide testing and vaccination sites as soon as these resources become available and staff should receive training in emergency preparedness, including trauma-informed care and ventilator use. No consensus was reached regarding unsupervised take-home dosing or the mandatory requirement of testing and vaccination for patients and staff.
conclusionThe global prevalence of opioid use disorders and the urgent need for MOUD suggest that pandemic preparation policies for MOUD could benefit from a more coordinated international approach that avoids disruption of services especially for vulnerable patients living in poverty.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.